VINEETLAB Stock View

Vineet Laboratories Ltd

VINEETLAB Stock View

(NSE)

Trade

₹ 70.05

-1.09 | -1.56

Market Cap ₹( Cr.)
643.49

Proj. P/E (x)

Proj. P/BV (x)

Proj. ROE (%)

Proj EV / EBITDA (x)
--

Proj. Revenue ( Cr.)

Last Updated On.
03-Dec-2023

 

Copy Link

Vineet Laboratories Limited is engaged in the business of drug intermediates and bulk drugs. It specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. It also exports API intermediates, fine chemicals, and custom synthesis molecules.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data